Statin use vs. average non-HDL cholesterol levels in Congo

Congo: Statin use vs. average non-HDL cholesterol levels was 2.8 in 2018. ▬ Flat

Latest (2018)
2.8
Change on year
unchanged
World rank
163rd
of 191 countries
All-time high
2.9
in 1982
All-time low
2.8
in 1980
Years of data
39
1980–2018

Statin use vs. average non-HDL cholesterol levels in Congo, 1980–2018

01231980199920181980: 2.81981: 2.81982: 2.91983: 2.91984: 2.91985: 2.91986: 2.91987: 2.91988: 2.91989: 2.91990: 2.91991: 2.91992: 2.91993: 2.91994: 2.91995: 2.91996: 2.91997: 2.91998: 2.91999: 2.92000: 2.92001: 2.92002: 2.92003: 2.92004: 2.92005: 2.92006: 2.92007: 2.92008: 2.92009: 2.92010: 2.92011: 2.92012: 2.92013: 2.92014: 2.92015: 2.82016: 2.82017: 2.82018: 2.8

Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.

Analysis

The most recent figure for statin use vs. average non-hdl cholesterol levels in Congo is 2.8, measured in 2018. That is the lowest value across all 39 years on record.

Compared with earlier readings it is down 3.4% over ten years.

Over the whole period, statin use vs. average non-hdl cholesterol levels in Congo peaked at 2.9 in 1982 and was at its lowest, 2.8, in 1980.

Congo ranks 163rd of 191 countries on this measure, in the bottom quarter.

Averages by decade

DecadeAverage LowestHighest Years
1980s 2.88 2.8 2.9 10
1990s 2.9 2.9 2.9 10
2000s 2.9 2.9 2.9 10
2010s 2.86 2.8 2.9 9

Countries ranked near Congo

  1. 163 Angola 2.8 compare
  2. 163 Burundi 2.8 compare
  3. 163 Cape Verde 2.8 compare
  4. 163 Central African Republic 2.8 compare
  5. 163 Chad 2.8 compare
  6. 163 Cote d'Ivoire 2.8 compare
  7. 163 Democratic Republic of Congo 2.8 compare
  8. 163 Equatorial Guinea 2.8 compare
  9. 163 Eswatini 2.8 compare
  10. 163 Gabon 2.8 compare
  11. 163 Guinea-Bissau 2.8 compare
  12. 163 Kenya 2.8 compare
  13. 163 Liberia 2.8 compare
  14. 163 Morocco 2.8 compare
  15. 163 Namibia 2.8 compare
  16. 163 Niger 2.8 compare
  17. 163 Sierra Leone 2.8 compare
  18. 163 Togo 2.8 compare
  19. 163 Uganda 2.8 compare
  20. 163 Zimbabwe 2.8 compare

See the full ranking of 191 places →

More reference data data for Congo

All data for Congo →

Frequently asked questions

What is statin use vs. average non-hdl cholesterol levels in Congo?
Statin use vs. average non-hdl cholesterol levels in Congo was 2.8 in 2018, according to World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
What is the highest statin use vs. average non-hdl cholesterol levels recorded in Congo?
The highest recorded value was 2.9 in 1982.
What is the lowest statin use vs. average non-hdl cholesterol levels recorded in Congo?
The lowest recorded value was 2.8 in 1980.
How does Congo rank for statin use vs. average non-hdl cholesterol levels?
Congo ranks 163rd out of 191 countries with data for 2018.
Is statin use vs. average non-hdl cholesterol levels rising or falling in Congo?
Over the last ten years it is down 3.4%. The long-run trend across the full record is flat.
Where does this Congo data come from?
The figures come from World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as part of Statin use vs. average non-HDL cholesterol levels. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 39 observations, free to reuse under CC BY 4.0 (Our World in Data).

About this data

Indicator
Statin use vs. average non-HDL cholesterol levels
Source
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
191 places, 7,449 data points, 1980–2018
Last refreshed

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.